1. Academic Validation
  2. XIB4035, a novel nonpeptidyl small molecule agonist for GFRalpha-1

XIB4035, a novel nonpeptidyl small molecule agonist for GFRalpha-1

  • Neurochem Int. 2003 Jan;42(1):81-6. doi: 10.1016/s0197-0186(02)00053-0.
Kimiko Tokugawa 1 Kyoko Yamamoto Mariko Nishiguchi Takumi Sekine Masahiko Sakai Tomokazu Ueki Shigeyuki Chaki Shigeru Okuyama
Affiliations

Affiliation

  • 1 CNS Diseases Research, Medicinal Pharmacology Laboratory, Medicinal Research Laboratories, Taisho Pharmaceutical Co. Ltd., 1-403 Yoshino-cho, Saitama, Saitama 330-8530, Japan.
Abstract

We investigated the agonistic activities of N(4)-(7-chloro-2-[(E)-2-(2-chloro-phenyl)-vinyl]-quinolin-4-yl)-N(1),N(1)-diethyl-pentane-1,4-diamine (XIB4035), at the glial cell line-derived neurotrophic factor (GDNF) family receptoralpha-1(GFRalpha-1) in Neuro-2A cells, a mouse neuroblastoma cell line which is a suitable model for investigating functions mediated through GFRalpha-1. XIB4035 concentration-dependently inhibited [(125)I]GDNF binding in Neuro-2A cells with an IC(50) of 10.4 microM. GDNF induced autophosphorylation of RET protein, and promoted neurite outgrowth in Neuro-2A cells. XIB4035, like GDNF, induced RET autophosphorylation in the Neuro-2A cells. Moreover, XIB4035 promoted neurite outgrowth in a concentration-dependent manner. These results show that XIB4035 may act as an agonist at GFRalpha-1 receptor complex, and mimic neurotrophic effects of GDNF in Neuro-2A cells. This is an interesting finding showing that a nonpeptidyl small molecule is capable of inducing activation of a receptor that normally bind a relatively large protein ligand such as GDNF.

Figures
Products